| Release |
Date |
Change Notifications |
| Title |
CN No. |
| 61 |
13 August 2024 |
Tuberculosis |
33 - 2024 |
| Necrotising Fasciitis |
32 - 2024 |
| 60 |
18 April 2024 |
Issue 03 |
| Sexually Transmitted Disease |
23 - 2024 |
| Issue 02 |
| Tropical Viruses |
13 - 2024 |
| Ankylosing Spondylitis and Eye Disease |
12 - 2024 |
| Coronavirus Vaccination |
10 - 2024 |
| Issue 01 |
| Issue 01 was superseded by Issue 02 prior to publication. |
| 59 |
29 January 2024 |
Splenectomy & ITP |
38 - 2023 |
| 58 |
15 November 2023 |
Coronavirus Infection (COVID-19) |
33 - 2023 |
| 57 |
15 November 2023 |
Changes arising from the FAIR III report |
17 - 2023 |
| 56 |
04 July 2023 |
Tuberculosis |
25 - 2023 |
| Tissue and Cell Allograft Recipients |
14 - 2023 |
| 55 |
09 May 2023 |
Tropical Viruses |
12 - 2023 |
| 54 |
12 April 2023 |
Malaria |
21 - 2023 |
| Mpox (Monkeypox) |
13 - 2023 |
| 53 |
13 December 2022 |
Infectious Disease - Contact With |
52 - 2022 |
| Coronavirus Infection (COVID-19) |
51 - 2022 |
| 52 |
12 September 2022 |
Table of Immunisations |
55 - 2022 |
| Steroid Therapy |
54 - 2022 |
| Basal Cell Carcinoma |
53 - 2022 |
| 51 |
31 May 2022 |
Monkeypox |
41 - 2022 |
| Immunosuppression |
38 - 2022 |
| 50 |
26 April 2022 |
Yellow Fever |
21 - 2022 |
| 49 |
07 April 2022 |
Coronavirus Infection |
30 - 2022 |
| 48 |
16 March 2022 |
Diseases of Unknown Aetiology |
17 - 2022 |
| Cervical Dysplasia |
16 - 2022 |
| Body Piercing |
15 - 2022 |
| Psoriasis |
14 - 2022 |
| Infertility |
13 - 2022 |
| 47 |
22 February 2022 |
Complementary Therapy |
04 - 2022 |
| 46 |
04 August 2021 |
Thrush - Oral & Vaginal |
30 - 2021 |
| Inflammatory Eye Disease |
28 - 2021 |
| Infertility |
27 - 2021 |
| Immunisation |
26 - 2021 |
| Haematological Disease |
24 - 2021 |
| Coronavirus Vaccination |
23 - 2021 |
| Coronavirus Infection |
22 - 2021 |
| Colitis, Proctitis and Gastrointestinal Disease |
20 - 2021 |
| Acne and Teratogenic Medications |
19 - 2021 |
| 45 |
11 May 2021 |
Transfusion |
14 - 2021 |
| Immunoglobulin Therapy |
13 - 2021 |
| Immune Thrombocytopenia |
12 - 2021 |
| 44 |
21 January 2021 |
COVID-19 Vaccination |
05 - 2021 |
| 43 |
16 December 2020 |
COVID-19 Vaccination |
74 - 2020 |
| 42 |
07 October 2020 |
Sexually Transmitted Disease |
61 - 2020 |
| Systemic Lupus Erythematosus |
46 - 2020 |
| South American Trypanosomiasis Risk |
44 - 2020 |
| Infection - Chronic |
43 - 2020 |
| Tamoxifen |
42 - 2020 |
| 41 |
15 July 2020 |
Tamiflu® and Relenza® |
40 - 2020 |
| Infection - Acute |
39 - 2020 |
| Viral Haemorrhagic Fever |
38 - 2020 |
| Rabies |
37 - 2020 |
| Animal Bite |
36 - 2020 |
| 40 |
24 June 2020 |
Coronavirus Infection |
33 - 2020 |
| 39 |
23 March 2020 |
Coronavirus Infection |
16 - 2020 |
| 38 |
24 February 2020 |
Coronavirus Infection |
10 - 2020 |
| 37 |
17 February 2020 |
Coronavirus Infection |
08 - 2020 |
| 36 |
24 January 2020 |
Coronavirus Infection |
05 - 2020 |
| 35 |
12 November 2019 |
Surgery |
16 - 2019 |
| 34 |
30 September 2019 |
Ocular Surgery |
32 - 2019 |
| Laser Treatment |
31 - 2019 |
| Sexually Transmitted Disease |
23 - 2019 |
| Malignancy |
21 - 2019 |
| Inflammatory Bowel Disease |
20 - 2019 |
| Hepatitis C |
19 - 2019 |
| Eye Disease |
18 - 2019 |
| Complementary Therapy |
17 - 2019 |
| Viral Haemorrhagic Fever |
15 - 2019 |
| Tissue Safety Entry |
14 - 2019 |
| Pre- and Post-Exposure Prophylaxis for HIV |
13 - 2019 |
| Hepatitis A |
12 - 2019 |
| 33 |
26 September 2018 |
Vasculitis |
33 - 2018 |
| Transgender Individual |
32 - 2018 |
| Thyroid Disease |
31 - 2018 |
| Reyes Syndrome |
30 - 2018 |
| Laser Treatment |
29 - 2018 |
| Infection - Chronic |
28 - 2018 |
| Infection - Acute |
27 - 2018 |
| Herpes - Ocular |
25 - 2018 |
| Eye Disease |
24 - 2018 |
| Blind Donor |
23 - 2018 |
| 32 |
26 July 2018 |
Haemodilution algorithm |
07 - 2018 |
| 31 |
24 April 2018 |
Viral Haemorrhagic Fever |
15 - 2018 |
| Transfusion |
14 - 2018 |
| Tissue and Organ Recipients |
13 - 2018 |
| Prisons |
12 - 2018 |
| Hepatitis E |
10 - 2018 |
| Hepatitis A |
09 - 2018 |
| Central Nervous System Disease |
04 - 2018 |
| 30 |
17 January 2018 |
Toxoplasmosis |
02 - 2018 |
| Poisoning |
01 - 2018 |
| 29 |
27 November 2017 |
Bleeding Disorder |
50 - 2017 |
| Syphilis |
48 - 2017 |
| Sex Worker |
46 - 2017 |
| Inoculation Injury |
43 - 2017 |
| HTLV |
42 - 2017 |
| Homosexual and Bisexual Individuals |
40 - 2017 |
| HIV |
38 - 2017 |
| Hepatitis C |
36 - 2017 |
| Hepatitis B |
34 - 2017 |
| Complementary Therapy |
32 - 2017 |
| Body Piercing |
30 - 2017 |
| Addiction and Drug Abuse |
28 - 2017 |
| Tissue Safety Entry |
27 - 2017 |
| Tissue and Organ Recipients |
23 - 2017 |
| Radiation Therapy |
22 - 2017 |
| Age |
21 - 2017 |
| 28 |
01 August 2017 |
Malaria |
17 - 2017 |
| 27 |
24 February 2017 |
Malignancy |
05 - 2017 |
| 26 |
10 October 2016 |
Transfusion |
48 - 2016 |
| Marfan's Syndrome |
47 - 2016 |
| Hepatitis A |
46 - 2016 |
| Ehlers Danlos Syndrome |
45 - 2016 |
| Cardiomyopathy |
44 - 2016 |
| 25 |
13 July 2016 |
Xenotransplantation |
29 - 2016 |
| Severe Exercise Intolerance Syndrome (SEID) |
28 - 2016 |
| Osteogenesis Imperfecta |
27 - 2016 |
| Necrotising Fasciitis |
26 - 2016 |
| Fibromyalgia |
25 - 2016 |
| Endoscopy |
24 - 2016 |
| 24 |
02 February 2016 |
Viral Haemorrhagic Fever |
15 - 2016 |
| Tropical Viruses |
14 - 2016 |
| 23 |
18 January 2016 |
Viral Haemorrhagic Fever |
11 - 2016 |
| West Nile Virus |
09 - 2016 |
| Tropical Viruses |
08 - 2016 |
| Table of Immunisations |
04 - 2016 |
| 22 |
08 July 2015 |
Age |
16 - 2015 |
| 21 |
23 June 2015 |
Injectable Tanning Agents |
15 - 2015 |
| Complementary Therapy |
12 - 2015 |
| 20 |
17 March 2015 |
Infertility |
09 - 2015 |
| Complementary Therapy |
08 - 2015 |
| Communication Difficulties |
07 - 2015 |
| 19 |
20 October 2014 |
Viral Haemorrhagic Fever Risk |
43 - 2014 |
| 18 |
11 August 2014 |
Sex Change |
39 - 2014 |
| Homosexual and Bisexual Individuals |
36 - 2014 |
| Tissues Safety Entry |
32 - 2014 |
| SARS |
31 - 2014 |
| Haematological Disease |
30 - 2014 |
| 17 |
31 March 2013 |
Paratyphoid and Typhoid |
15 - 2013 |
| South American Trypanosomiasis Risk |
14 - 2013 |
| Sarcoidosis |
13 - 2013 |
| Mental Health Problems |
12 - 2013 |
| Malignancy |
11 - 2013 |
| Kidney Disease |
10 - 2013 |
| Hepatitis of Unknown Origin |
08 - 2013 |
| Central Nervous System Disease |
05 - 2013 |
| Aliretinoin, Toctino, Acne and Dermatitis |
03 - 2013 |
| Acupuncture |
02 - 2013 |
| 16 |
09 July 2013 |
Infection - Chronic |
10 - 2013 |
| Hepatitis B - Post Immunisation |
09 - 2013 |
| Hepatitis B |
08 - 2013 |
| 15 |
04 June 2013 |
West Nile Virus |
01 - 2013 |
| 14 |
29 June 2012 |
Toxoplasmosis |
18 - 2012 |
| Psoriasis |
17 - 2012 |
| Pregnancy |
16 - 2012 |
| Acne |
15 - 2012 |
| 13 |
28 March 2012 |
West Nile Virus |
05 - 2012 |
| 12 |
24 January 2012 |
Hepatitis C |
27 - 2011 |
| XMRV |
25 - 2011 |
| 11 |
06 December 2011 |
Immunosuppression |
21 - 2011 |
| Porphyria |
20 - 2011 |
| 10 |
08 August 2011 |
West Nile Virus |
11 - 2011 |
| 09 |
21 June 2011 |
Sexually Transmitted Disease |
09 - 2011 |
| Infertility |
08 - 2011 |
| BCG |
07 - 2011 |
| Immunisation - Live |
06 - 2011 |
| 08 |
01 September 2010 |
West Nile Virus |
09 - 2010 |
| 07 |
03 March 2010 |
Inoculation Injury |
04 - 2010 |
| Body Piercing |
02 - 2010 |
| 06 |
24 December 2009 |
Complementary Therapy |
35 - 2009 |
| Acupuncture |
33 - 2009 |
| 05 |
04 December 2009 |
Relenza® (Zanamivir) |
29 - 2009 |
| Tamiflu® (Oseltamivir) |
28 - 2009 |
| 04 |
21 May 2009 |
Age |
08 - 2009 |
| 03 |
02 January 2008 |
A change was made to the version control definitions and all Issue numbering information removed. |
| 02 |
01 November 2007 |
Public release – for changes see Appendix 1 - Changes to the Guidelines |
| 01 |
01 June 2007 |
Consultation release − not for implementation |